Evidence map›Paper›PMID 42168626›Full record

ArticleNature chemical biology2026

Cystine C-S bond cleavage fuels cysteine production under disulfide reductase deficiency.

Edward E Schmidt, Eszter Petra Jurányi, Colin G Miller, Sydney A Austad, Tamás Ditrói, Zoe M Seaford, Sang Jun Yoon, Reed C Noyd, Yun Pyo Kang, Justin R Prigge and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Edward E Schmidt *Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA. eschmidt@montana.edu.ORCID http://orcid.org/0000-0002-9959-4990
Eszter Petra Jurányi *Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.ORCID http://orcid.org/0000-0002-0563-4876
Colin G Miller *Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA.
Sydney A Austad *Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA.ORCID http://orcid.org/0009-0006-3086-5445
Tamás Ditrói *Department of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
Zoe M Seaford *Department of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA.
Sang Jun YoonDepartment of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Reed C NoydDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA.ORCID http://orcid.org/0000-0002-2698-0938
Yun Pyo KangDepartment of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Justin R PriggeDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT, USA.
Vivien CsikósDepartment of Anatomy and Histology, HUN-REN-UVMB Laboratory of Redox Biology, University of Veterinary Medicine, Budapest, Hungary.ORCID http://orcid.org/0000-0003-3773-2582
Martina Serrano AlvarezBiology Department, University of Seville, Seville, Spain.ORCID http://orcid.org/0009-0003-6104-2001
Katalin ErdélyiDepartment of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
Dóra KőváriDepartment of Anatomy and Histology, HUN-REN-UVMB Laboratory of Redox Biology, University of Veterinary Medicine, Budapest, Hungary.
Gina M DeNicolaDepartment of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Gina.DeNicola@moffitt.org.ORCID http://orcid.org/0000-0001-6611-6696
Peter NagyDepartment of Anatomy and Histology, HUN-REN-UVMB Laboratory of Redox Biology, University of Veterinary Medicine, Budapest, Hungary. peter.nagy@oncol.hu.ORCID http://orcid.org/0000-0003-3393-235X

Funding

Metabolic basis of the NADPH-independent disulfide reductase system in mouse liverR01DK123738 · NIDDK · MONTANA STATE UNIVERSITY - BOZEMAN · PI DENICOLA, GINA MARIE, SCHMIDT, EDWARD E · 2020 to 2022
$1.3M
Metabolic basis of the NADPH-independent disulfide reductase system in mouse liverR56DK123738 · NIDDK · MONTANA STATE UNIVERSITY - BOZEMAN · PI DENICOLA, GINA MARIE, SCHMIDT, EDWARD E · 2019 to 2019
$464k
Hepatocyte-targeted somatic-cell genetic complementation in miceR21OD026444 · OD · MONTANA STATE UNIVERSITY - BOZEMAN · PI SCHMIDT, EDWARD E · 2019 to 2020
$396k
Redox regulation in the hepatostatR21AG055022 · NIA · MONTANA STATE UNIVERSITY - BOZEMAN · PI ARNER, ELIAS S.J., NAGY, PETER · 2016 to 2017
$382k
Magyar Tudományos Akadémia (Hungarian Academy of Sciences) #K-22 143769Magyar Tudományos Akadémia (Hungarian Academy of Sciences) #MTA18/8/2023KPU.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DK123738U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21AG055022U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21OD026444U.S. Department of Health & Human Services | National Institutes of Health (NIH) R56DK123738U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30-CA076292
6 · The paper itself

Abstract

All organisms have thioredoxin reductase (TR) or glutathione reductase (GR), the only enzymes that use reduced nicotinamide adenine dinucleotide phosphate to reduce cytosolic disulfides into thiols, thereby powering deoxyribonucleotide biosynthesis, elimination of oxidants, oxidative damage repair and reduction of the disulfide nutrient cystine into the thiol amino acid cysteine. Hence, TR/GR-null bacteria or yeast are inviable; yet, remarkably, mice with TR/GR-null livers thrive, in part by synthesizing life-sustaining cysteine through alternative pathways that evolved in metazoans. Although TR/GR-null livers generate some of their cysteine through the serine transsulfuration pathway, we here show that most cysteine in TR/GR-null livers comes from a pathway in which pyridoxal-phosphate-dependent cleavage of a carbon-sulfur bond in cystine generates cysteine persulfide, which decomposes nonenzymatically into cysteine. This potent yet previously unrecognized pathway is regulated by cellular levels of sulfur metabolites and represents a potent cytoprotective response that might be induced in most mammalian cells under conditions that chronically elevate cytosolic cystine levels.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.